stockrowGlass House Brands Inc. (GLAS) vs Organigram Global Inc. (OGI)
- Glass House Brands Inc. GLAS 2.17 −2.69%
- Organigram Global Inc. OGI 0.91 −2.15%
Glass House Brands Inc. and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. Glass House Brands Inc. is the larger, with a market value of $172.7M against $131.1M — 1.3× the size. Glass House Brands Inc. has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.0×. Organigram Global Inc. grew revenue faster over the last twelve months: 39.5% against −15.4%. Organigram Global Inc. has the higher net margin (28.4% vs −36.2%) and the higher return on invested capital (−1.53% vs −23.4%). Across the 17 metrics below, Organigram Global Inc. leads on 16 and Glass House Brands Inc. on 1.
Valuation
Profitability
| Metric | GLAS | OGI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 31.97% | 36.47% | 53.51% |
| Operating margin | (23.18%) | (3.91%) | 0.00% |
| Net margin | (36.19%) | 28.44% | (2.45%) |
| Free cash flow margin | (20.78%) | (9.46%) | 0.00% |
| Return on equity | (74.02%) | 20.20% | (0.80%) |
| Return on assets | (19.78%) | 12.70% | (1.67%) |
| Return on invested capital | (23.36%) | (1.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack